Versant Venture Management, LLC Long-Term Concentrated

CIK: 0001560009 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Oct 5, 2018

Total Value ($000): $294,005,109 (100.0% shares, 0.0% debt)

Holdings (10)

CRSP CRISPR Therapeutics AG 54.4%

Value ($000) $160,053,562 Shares 3,608,874 Est. Cost $41.27 Unrealized +26.9%

— Audentes Therapeutics, Inc. 16.2%

Value ($000) $47,690,708 Shares 1,204,615 Est. Cost $17810.00 Unrealized —

VCYT Veracyte, Inc. 11.7%

Value ($000) $34,534,911 Shares 3,616,221 Est. Cost $11.03 Unrealized 0.0%

OCUL Ocular Therapeutix, Inc. 5.2%

Value ($000) $15,241,842 Shares 2,215,384 Est. Cost $20.09 Unrealized -68.8%

— CymaBay Therapeutics, Inc. 4.1%

Value ($000) $12,018,432 Shares 1,084,696 Est. Cost $9871.60 Unrealized —

— Second Sight Medical Products, Inc. 2.9%

Value ($000) $8,536,653 Shares 4,492,975 Est. Cost $1210.00 Unrealized —

— ImmuneDesign Corp. 2.6%

Value ($000) $7,618,325 Shares 2,208,210 Est. Cost $7580.00 Unrealized —

— Achaogen, Inc. 1.7%

Value ($000) $5,111,796 Shares 1,281,152 Est. Cost $13050.00 Unrealized —

— Clovis Oncology, Inc. 1.0%

Value ($000) $2,991,481 Shares 101,855 Est. Cost $56000.00 Unrealized —

— OpGen, Inc. 0.1%

Value ($000) $207,399 Shares 102,167 Est. Cost $1780.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CRSP	CRISPR Therapeutics AG	3,608,874	$160,053,562	54.4%	$41.27	+26.9%	Common Stock	H17182108
—	Audentes Therapeutics, Inc.	1,204,615	$47,690,708	16.2%	$17810.00	—	Common Stock	05070R104
VCYT	Veracyte, Inc.	3,616,221	$34,534,911	11.7%	$11.03	0.0%	Common Stock	92337F107
OCUL	Ocular Therapeutix, Inc.	2,215,384	$15,241,842	5.2%	$20.09	-68.8%	Common Stock	67576A100
—	CymaBay Therapeutics, Inc.	1,084,696	$12,018,432	4.1%	$9871.60	—	Common Stock	23257D103
—	Second Sight Medical Products, Inc.	4,492,975	$8,536,653	2.9%	$1210.00	—	Common Stock	81362J100
—	ImmuneDesign Corp.	2,208,210	$7,618,325	2.6%	$7580.00	—	Common Stock	45252L103
—	Achaogen, Inc.	1,281,152	$5,111,796	1.7%	$13050.00	—	Common Stock	004449104
—	Clovis Oncology, Inc.	101,855	$2,991,481	1.0%	$56000.00	—	Common Stock	189464100
—	OpGen, Inc.	102,167	$207,399	0.1%	$1780.00	—	Common Stock	68373L109